Labshake search
Citations for Stemcell Technologies :
51 - 100 of 1190 citations for trans 2 2 4 Methoxyphenyl 2 oxoethyl cyclohexane 1 carboxylic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% SM1 (Stemcell Technologies; 05792), 5 mM L-Glutamine (Stemcell Technologies ...
-
bioRxiv - Genetics 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 2 mM EDTA (Stemcell Technologies) and pooled for antibody staining.
-
bioRxiv - Molecular Biology 2022Quote: ... & 300 IU/mL IL-2 (STEMCELL Technologies). T cells were seeded at 2 × 106 cells/mL (typically 10×106 cells per well of a 6-well plate ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... heparin solution (2 mg/mL, STEMCELL Technologies), recombinant bFGF (20 ng/mL ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Cancer Biology 2023Quote: ... heparin (2 mg/mL, STEMCELL Technologies 07980), 1% penicillin/streptomycin ...
-
bioRxiv - Pathology 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Developmental Biology 2024Quote: ... in APEL 2 base medium (Stemcell Technologies). On day 3 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 2 μg/ml heparin (Stemcell Technologies, 07980), and penicillin-streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 2% SM1 (STEMCELL Technologies, 05792), 5 mM L-glutamine (STEMCELL Technologies ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2% SM1 supplement (Stem Cell Technologies), and subsequently fed with astrocyte-conditioned BrainPhys media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2022Quote: ... supplemented with 2% SM1 (StemCell Technologies #05711), 40 μg/mL gentamycin and 2.5 μg/mL Amphotericin B medium ...
-
bioRxiv - Cell Biology 2023Quote: ... and 2.5µM of IWP-2(Stemcell Technologies). Rudibaugh2 organoid media was supplemented with 100ng/mL SHH(VWR ...
-
bioRxiv - Immunology 2024Quote: ... 150 ng/µLIL-2 (StemCell Technologies #78081), 5 ug/mL anti-IL-4 (clone 11B11 ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2% NeuroCult SM1 Supplement (STEMCELL Tech.). For immunofluorescence ...
-
bioRxiv - Neuroscience 2024Quote: ... XAV939 (2 μM, Stemcell Technologies, Cat # 72672) and LDN-193189 (100 nM ...
-
bioRxiv - Neuroscience 2024Quote: ... XAV939 (2 μM, Stemcell Technologies, Cat # 72672) and LDN-193189 (100 nM ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 2 μM IWP2 (STEMCELL Technologies, 72124). The medium was refreshed daily for 4 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... heparin (2 µg/ml; Stemcell Technologies, Inc.); 20 ng/mL human EGF and FGFb and 10 ng/mL platelet derived growth factors AA and BB (PeproTech ...
-
bioRxiv - Developmental Biology 2021Quote: Unsorted cells at day 6 (4+2) of differentiation were cultured in MethoCult 04434 (Stem Cell Technologies) in 35 mm dishes ...
-
bioRxiv - Bioengineering 2022Quote: ... Both UC3-4 and UCS-2 hiPSCs were frozen in mFreSR medium (Stem Cell Technologies, Vancouver, Canada) and stored under cryogenic conditions in a vapor phase liquid nitrogen dewar ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 μM all-trans retinoic acid (RA, STEMCELL Technologies, 72262), and the removal of Glial Cell Derived Neurotrophic Factor (GDNF).
-
bioRxiv - Bioengineering 2021Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies; 72262) for 5 days ...
-
bioRxiv - Genomics 2020Quote: ... All-Trans Retinoic Acid 0.1 μM (RA, STEMCELL Technologies, Cat.: #72262), and Purmorphamine 0.5 μM (PMN ...
-
bioRxiv - Bioengineering 2024Quote: ... and 0.5 µM All-trans retinoid acid (Stem Cell Technologies, 72262). After differentiation ...
-
bioRxiv - Bioengineering 2024Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies, 72262).
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1), 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF ...
-
bioRxiv - Immunology 2023Quote: ... Isolated cells were cultured for 1-2 weeks in StemSpan Medium (Stemcell Technologies) supplemented with 10 ng/ml interleukin (IL)-3 ...
-
bioRxiv - Genomics 2024Quote: ... then cells were replated 1:2 in STEMdiff Neural Progenitor Medium (Stemcell Technologies) for NPC expansion.
-
bioRxiv - Developmental Biology 2024Quote: ... it was switched to PXGL medium (N2B27 medium supplemented with 1 μM PD0325901, 2 μM XAV939 [STEMCELL Technologies, 72674], 2 μM Gö6983 [STEMCELL Technologies, 72462], and 10 ng/mL LIF), refreshed daily for an additional 8-10 days before passaging ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 H3.1-K27M (GSC3, GSC4) cellular models were grown in NeurocultTM medium supplemented with heparin (2 μg/mL, Stemcell Technologies), EGF/FGF (20ng/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... heparin (2 μg/ml; Stem Cell Tech, #07980), and Antibiotic-Antimycotic solution (0.1% ...
-
bioRxiv - Genetics 2022Quote: ... 2 μM doxycycline and CloneR supplement (StemCell Technologies) to enhance the viability of single cells ...
-
bioRxiv - Neuroscience 2020Quote: ... and heparin (2 μg/mL, StemCell Technologies, #07980).
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/mL Heparin (Stem Cell Technologies #07980) and L-glutamine (2mM ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% NeuroCult SM1 supplement (STEMCELL Technologies) and 1% penicillin/streptomycin (Gibco) ...
-
bioRxiv - Cell Biology 2021Quote: ... containing 2% NeuroCult SM1 supplement (StemCell Technologies, 05711), 1% L-glutamine (Corning ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (Stem Cell Technologies), as previously described (Tominaga et al. ...
-
bioRxiv - Immunology 2022Quote: ... and/or rat serum (2%; Stem Cell Technologies) for 5min on ice prior to adding fluorescent antibodies (BioLegend ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% NeuroCult™ SM1 (STEMCELL Technologies, Cat# 05711), 1% N-2 Supplement (Thermo Scientific ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 μM of XAV939 (#72674, StemCell Technologies). The medium was changed daily until day 11 ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 μMY27632 (Stemcell Technologies, 129830-38-2)) on day 0 ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM of XAV939 (STEMCELL Technologies, #72674) were added to induce cerebro-cortical differentiation ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2×105 hDR4+ HSCs (purchased from Stemcell Technologies Inc ...